Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL973821 | 1.00 | ALDH1A1 (0.33) | ALDH1A1NPC1RAB9ASMN1; SMN2TET2 | |
| SCHEMBL9302994 | 0.86 | TET2 (0.32) | TET2EGLN1 | |
| SCHEMBL27823589 | 0.84 | EGLN1 (0.32) | TET2EGLN1 | |
| SCHEMBL26650993 | 0.80 | CCR2 (0.34) | ALDH1A1EGLN1 | |
| Acetone SCHEMBL8986804 | 0.80 | — | — | |
| SCHEMBL10701214 | 0.80 | — | — | |
| SCHEMBL9814664 | 0.75 | MEN1 (0.32) | ALDH1A1 | |
| SCHEMBL3019700 | 0.69 | EGLN1 (0.39) | ALDH1A1TET2EGLN1 | |
| SCHEMBL27050 | 0.67 | — | — | |
| SCHEMBL27839074 | 0.67 | MMP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103885-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | GOLD BOND BUILDING PRODUCTS LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20250052057-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2025-02-13 | — | — | US | disclosed |
| US-12152385-B2 | Cementitious panels with swellable materials and methods of providing a moisture or water barrier in cementitious panels using swellable materials | GOLD BOND BUILDING PRODUCTS, LLC (US) | 2024-11-26 | — | — | US | disclosed |
| US-20230366197-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2023-11-16 | — | — | US | disclosed |
| US-11801662-B2 | Cementitious panels with polymeric-film facing material | GOLD BOND BUILDING PRODUCTS, LLC (US) | 2023-10-31 | — | — | US | disclosed |
| US-11708692-B2 | Cementitious panels with swellable materials and methods of providing a moisture or water barrier in cementitious panels using swellable materials | GOLD BOND BUILDING PRODUCTS, LLC (US) | 2023-07-25 | — | — | US | disclosed |
| US-20200207060-A1 | Cementitious Panels with Polymeric-Film Facing Material | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2020-07-02 | — | — | US | disclosed |
| US-20200208398-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2020-07-02 | — | — | US | disclosed |
| EP-1366111-B2 | WATER-ABSORBING AGENT, METHOD FOR THE PRODUCTION AND THE UTILIZATION THEREOF | BASF SE (DE) | 2020-04-29 | — | — | EP | disclosed |
| US-20150344621-A1 | AQUEOUS SOLUTION COMPRISING ACRYLIC ACID AND THE CONJUGATE BASE THEREOF | BASF SE (DE) | 2015-12-03 | — | — | US | disclosed |
| EP-1358863-A1 | Absorbent article containing a skin care composition | SCA Hygiene Products AB (SE) | 2003-11-05 | — | — | EP | disclosed |
| EP-1347790-A1 | ABSORBENT COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-01 | — | — | EP | disclosed |
| US-20030144386-A1 | Mixtures of hydrogel-forming polymers and building materials | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-31 | — | — | US | disclosed |
| US-20030040570-A1 | Preparation of pure (meth)acrylic acid and (meth)acrylates | BASF AKIENGESELLSCHAFT (DE) | 2003-02-27 | — | — | US | disclosed |
| WO-2003014172-A2 | METHOD FOR PRODUCING WATER-ABSORBENT RESINS | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-20 | — | — | WO | disclosed |
| US-20020165288-A1 | Water insoluble water-swellable hydrogels; for use in diaper and hygiene articles | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-07 | — | — | US | disclosed |
| US-20020128618-A1 | Hydrogels | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-12 | — | — | US | disclosed |
| WO-2002053199-A1 | HYDROGELS COATED WITH STERIC OR ELECTROSTATIC SPACERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | WO | disclosed |
| WO-2002053198-A1 | ABSORBENT COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | WO | disclosed |
| US-6414214-B1 | HYDROGEL-FORMING POLYMER HAVING SPECIFIED SALINE FLOW CONDUCTIVITY, ABSORPTION UNDER LOAD AND FRANGIBILITY INDEX; DIAPERS, INCONTINENCE PADS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103885-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | DSG1, AQP4, WAPL | ALDH1A1 2689/4885NPC1 2521/4885RAB9A 3140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.